Glitazone scrips up 34%

The number of scrips for glitazones increased by 33.5 per cent between 2005 and 2006 in England, according to a DoH Information Centre report.

The report on diabetes prescribing in England revealed that 2.1 million prescriptions for glitazones, at a cost of £94 million, were written in 2006.

Rosiglitazone remained the most commonly prescribed glitazone, with over 1.4 million prescriptions.

The use of rosiglitazone in combination with metformin increased to exceed rates of pioglitazone prescriptions.

Findings that link rosiglitazone to a 63 per cent increased risk of death from cardiovascular cause, are expected to affect future prescribing patterns.

Last month the European Medicines Agency said prescribing information for rosiglitazone must include a warning that in patients with ischaemic heart disease rosiglitazone should only be used after careful evaluation of risk.

Prescribing for diabetes in England

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...

Enhanced service contract for GP practices delivering COVID-19 vaccine revealed

Enhanced service contract for GP practices delivering COVID-19 vaccine revealed

GP practices have until midnight on 7 December to sign up to a COVID-19 enhanced...

Five GP practices a week inspected by CQC during pandemic second wave

Five GP practices a week inspected by CQC during pandemic second wave

The CQC has inspected five GP practices a week in England since the second wave of...

Pregnant women and under-18s will not be offered COVID-19 vaccine

Pregnant women and under-18s will not be offered COVID-19 vaccine

Pregnant women, children and under-18s will not be recommended for routine COVID-19...

GP training: How an audit e-portfolio log entry is assessed

GP training: How an audit e-portfolio log entry is assessed

The second of two articles on audit during GP training looks at how the quality improvement...